|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7088 | |
| C12N 15/113 |
| (11) | Number of the document | 2956176 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14751357.6 |
| Date of filing the European patent application | 2014-02-14 | |
| (97) | Date of publication of the European application | 2015-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/016546 |
| Date | 2014-02-14 |
| (87) | Number | WO 2014/127268 |
| Date | 2014-08-21 |
| (30) | Number | Date | Country code |
| 201361764969 P | 2013-02-14 | US | |
| 201361880779 P | 2013-09-20 | US |
| (72) |
ALEXANDER, Veronica, J., US
VINEY, Nicholas, J., US
WITZTUM, Joseph, L., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |
| MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS |